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The genome sequence strain 104 of the opportunistic pathogen Mycobacterium avium was isolated from an
adult AIDS patient in Southern California in 1983. Isolates of non-paratuberculosis M. avium from 207 other
patients in Southern California and elsewhere were examined for genotypic identity to strain 104. This process
was facilitated by the use of a novel two-step approach. In the first step, all 208 strains in the sample were
subjected to a high-throughput, large sequence polymorphism (LSP)-based genotyping test, in which DNA
from each strain was tested by PCR for the presence or absence of 4 hypervariable genomic regions. Nineteen
isolates exhibited an LSP type that resembled that of strain 104. This subset of 19 isolates was then subjected
to high-resolution repetitive sequence-based PCR typing, which identified 10 isolates within the subset that
were genotypically identical to strain 104. These isolates came from 10 different patients at 5 clinical sites in
the western United States, and they were isolated over a 17-year time span. Therefore, the sequenced genome
of M. avium strain 104 has been associated with disease in multiple patients in the western United States.
AlthoughM. avium is known for its genetic plasticity, these observations also show that strains of the pathogen
can be genotypically stable over extended time periods.
The Mycobacterium avium complex (MAC) includes the
most clinically significant of the environmental mycobacteria
that opportunistically infect susceptible humans. Sequencing of
the genome of M. avium strain 104 is nearing completion by
The Institute for Genomic Research (TIGR). Strain 104 was
isolated in the mid-1980s from an adult patient with AIDS in
Southern California. Like many genome sequence strains, its
laboratory characteristics are amenable to genetic analysis, but
there is little clinical or epidemiologic information regarding
its incidence in human MAC disease. The draft sequence of
strain 104 has 4,480 predicted open reading frames (ORFs).
Annotation of the strain 104 genome identified genes that are
shared with other virulent mycobacteria as well as genes that
are unique to MAC (23). Whole-genome DNA microarray and
PCR evaluation of 43 clinical isolates of M. avium relative to
strain 104 revealed a 13.5% polymorphism rate between iso-
lates (23). In comparison to M. tuberculosis, this represents an
eightfold-greater strain-to-strain variability on the genomic
level. In view of this genomic heterogeneity, the extent to
which strain 104 is representative of virulent MAC isolates is
an open question.
To assess the clinical incidence of infections involving strain
104, we examined a sample of clinical isolates of M. avium from
Southern California and elsewhere for genotypic identity with
the genome sequence strain. Although these isolates were ini-
tially classified as M. avium subsp. avium, new data suggest that
true M. avium subsp. avium strains infect a narrow spectrum of
avian hosts and are described genotypically by a characteristic
restriction fragment length polymorphism with IS1245, by the
presence of IS901, and by a limited temperature range in which
they can be grown (15). Mijs and colleagues recommended the
subspecies name “hominissuis” for the more genetically poly-
morphic M. avium strains that grow in a wider temperature
range of 24 to 45°C and classically infect pigs and humans. The
M. avium isolates used in this study are phenotypically consis-
tent with M. avium subsp. hominissuis (15). However, because
most of the isolates were not assessed to determine whether
they have the genotypic characteristics of M. avium subsp.
hominissuis, they are referred to in this study by the umbrella
term “M. avium.”
M. avium isolates are known for their genotypic polymor-
phism (1–3, 8, 12, 19, 20, 24). High-resolution pathogen geno-
typing approaches, such as pulsed-field gel electrophoresis and
restriction fragment length polymorphism (RFLP) with
IS1245, have rarely linked MAC isolates outside of geograph-
ically restricted samples. Because these methods are time con-
suming, labor intensive, and not portable (i.e., difficult to stan-
dardize between laboratories), few molecular epidemiologic
studies of MAC have been conducted that encompass broader
geographic samples. Recently, a commercial repetitive se-
quence-based PCR (rep-PCR) system was shown to deliver
resolving power equivalent to that of RFLP with IS1245 (6).
This method is rapid and reproducible enough for analysis of
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large samples, but its cost can be restrictive. To stratify strains
of interest for high-resolution typing, preliminary analysis with
a moderate resolution typing method can be cost effective. For
example, a two-tier approach was used for many years in mo-
lecular epidemiological analysis of Mycobacterium tuberculosis.
Spoligotyping was used to presumptively link isolates prior to
high-resolution typing by the more labor-intensive RFLP
method (4, 10, 26). To search a large strain sample for geno-
typic identity to strain 104, a high-throughput tool was needed
that could be applied like spoligotyping to presumptively link
isolates prior to high-resolution typing.
Sequencing and annotation of multiple mycobacterial ge-
nomes has helped to identify large sequence polymorphisms
(LSPs), defined as insertions or deletions comprising at least
one ORF. Varying patterns of LSP occurrence offer an alter-
native method of typing mycobacteria in a quick, PCR-based
method (7, 9). LSPs are thought to be relatively stable and
unique events, and they have been used to identify genetic
linkages within and between Mycobacterium species (11, 16,
25). As a simple, inexpensive method to interrogate strains for
stable polymorphisms, LSP typing by PCR can streamline the
molecular epidemiological analysis of a large sample, espe-
cially when the sample set is screened for isolates that are
genotypically related to a reference strain. It can be expected
that isolates that share the reference strain’s LSP type are
more likely than other isolates to share the reference strain’s
high-resolution DNA fingerprint (e.g., IS1245 RFLP or rep-
PCR patterns). We used this strategy to screen a large clinical
isolate sample set for epidemiologically unlinked isolates that
share genotypic identity with the genome sequence strain M.
avium strain 104.
MATERIALS AND METHODS
M. avium strains. The analysis was conducted on strain 104 and 207 additional
archived human clinical isolates of M. avium from 6 geographical regions: Southern
California (75 strains); Seattle, Washington (22 strains); Little Rock, Arkansas (5
strains); The Netherlands (61 strains); Sa˜o Paulo, Brazil (22 strains); and Mon-
treal, Quebec, Canada (23 strains). Each isolate originated from a single, anon-
ymous patient. Sites of isolation included sputum, bronchoalveolar lavage fluid,
blood, lymph node biopsy, and unknown sites. The Southern California and The
Netherlands isolates came from patients at multiple clinical sites (6 and 35,
respectively), whereas the isolates from the other 4 regions originated from
patients in 1 or 2 clinical sites each. Human immunodeficiency virus coinfection
information was available for some, but not all, of the isolates. The isolates are
summarized in Table 1 and were originally isolated and archived from other
studies (2, 5, 6, 13, 17, 18, 23).
For most isolates, DNA was extracted at collaborating sites and shipped in
pure form to Seattle Biomedical Research Institute (SBRI) for analysis. In some
cases, the isolates were delivered to SBRI as viable bacterial cells. In those cases,
M. avium colonies were grown on Middlebrook 7H10 agar plates (Fisher Scien-
tific International, Hampton, NJ) containing oleic acid-albumin-dextrose-cata-
lase at 37°C, and DNA was extracted using the UltraClean microbial DNA
isolation kit (Mo Bio Laboratories, Carlsbad, CA). All DNA samples were
diluted to 10 g/ml in sterile water for analysis.
LSP typing PCR strategy. The 4 LSPs examined in this study were designated
LSP2, LSP7, HSD, and LSPP5. This nomenclature was consistent with prior
publications (14, 22, 23). Each consisted of a genomic region of 2.5 kb that was
present in some M. avium strains and absent in others. Criteria for their selection
are described in Results. PCR primers used to interrogate genomic DNA for the
presence or absence of each region are summarized in Table 2. Genomic DNA
from each isolate was interrogated with 4 multiplex PCRs, each of which tested
for one LSP.
Primers for LSP2 and LSP7 were described previously by Semret et al. (23).
For each of these LSPs, a left flanking primer (LFP) and a right flanking primer
(RFP) were designed. A third primer hybridized internally near the left end of
each region (left internal primer [LIP]). The presence of each region was indi-
cated by a PCR amplicon primed by the LFP and LIP. The absence of each
region was indicated by an amplicon primed by the two flanking primers.
The presence of the HSD region was detected in a similar manner. When the
HSD region was present, an amplicon was primed by the LFP and LIP, as in
LSP2 and LSP7. When the HSD region was absent, an amplicon was primed by
the LFP and an opposing primer that spanned the deletion junction (bridging
primer).
Preliminary analysis of LSPP5 found multiple polymorphisms in both border
regions. Therefore, a set of 4 primers was used to detect the presence or absence
of this LSP. When the region was present, two internal primers (LSPP5 LIP and
right internal primer) amplified an internal segment. When it was absent, flank-
ing primers (left and right) amplified across the junction as in LSP2 and LSP7.
Amplicon sizes expected from the multiplex PCRs testing for the presence and
absence of each region were as follows: LSP2, 954 bp (present) and 834 bp
(absent); LSP7, 181 bp (present) and 329 bp (absent); HSD, 480 bp (present) and
343 bp (absent); LSPP5, 794 bp (present) and 728 bp (absent).
PCR conditions. Except for HSD, the PCR was performed by combining 5 l
of 5 GC-rich PCR buffer, 2 l of 10 mM nucleotides, 1.5 l of 10 mM primer
mix, 2.5 l of GC-rich resolution solution (Roche Diagnostics, Basel, Switzer-
land), 1 l of 10 g/ml template, 1 U of Taq enzyme, and sterile water to make
25 l per reaction mixture. The HSD PCR mixture required the addition of 0.6
l of 2.5 mM MgCl2, which lowered the GC-rich resolution solution to 2 l per
reaction. PCR was performed with a PTC-200 Peltier thermocycler (MJ Re-
search, Boston, MA). Both LSP7 and LSPP5 used an initial denaturation step of
95°C for 3 min, followed by 36 cycles of 1 min at 58°C, followed by 1 min at 72°C.
PCR conditions for HSD began with an initial denaturation step at 95°C for 3
min followed by 36 cycles of denaturation at 95°C for 45 s, annealing at 55°C for
1 min, and elongation at 72°C for 1 min. PCR conditions for LSP2 included an
initial denaturation step at 94°C for 3 min, followed by 36 cycles of 45 s each at
94°C, 57°C, and 72°C. Amplicons were analyzed by 1% agarose gel electrophore-
sis with ethidium bromide staining in comparison to a 1-kb ladder (Sigma-
Aldrich Corp., St. Louis, MO). Sizing was confirmed by the ladder as well as by
correspondence to well-characterized positive- or negative-control strains (M.
avium strains 104 and HMC02, and M. avium subsp. paratuberculosis strain K10).
LSP typing nomenclature. An amplification result corresponding precisely in
size to the presence of a region was denoted with the number “2.” A result
TABLE 1. M. avium subsp. avium clinical isolates (n  208)
Location No. ofisolates
No. of
clinical
sites
Yr of collection Reference(s)
Southern California 75 6 1982–1994 2, 5
The Netherlands 61 35 1994–1996 13
Brazil 22 1 1998 18
Seattle, Wash. 22 2 1999–2001 5, 6, 17
Montreal, Canada 23 1 1999–2003 23
Arkansas 5 1 Prior to 2000 17
TABLE 2. PCR primers used for LSP typing
Primera Sequence Reference
LSP2 LFP TTTATCCGCCTGATCGAAAC 23
LSP2 RFP ATTCGTTCGTGTCGTCGTC 23
LSP2 LIP CACGATCTTGGCTTCCTCAG 23
LSP7 LFP GAGGTGGTGGACCTGCTG 23
LSP7 RFP CATCCGGTCTTCCAGCAC 23
LSP7 LIP CGGATCGCCCTACAGATAAC 23
HSD LFP AGGTCCATCTGCCCTGTTG This study
HSD LIP CCGAATACGCAAATCACCTT This study
HSD BP CAGGGCGTTTCACGGTC This study
LSPP5 RFP GTCATACGGCTGTCCTGGTT This study
LSPP5 LFP GGCACGACGACTATTTCCAT This study
LSPP5 RIP TGCTCAGGCCAACCCGCGC This study
LSPP5 LIP TACTGGGCGGCGCACCCGAC This study
a Abbreviations: LFP, left flanking primer; RFP, right flanking primer; LIP,
left internal primer; RIP, right internal primer; BP, bridging primer.
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corresponding precisely in size to the absence of a region was denoted with the
number “1.” If no amplification or anomalous bands were observed, the locus
was assigned an “X” (indeterminate). Thus, each isolate was assigned a 4-digit
LSP type, with results for each locus ordered as follows: HSD, LSP2, LSP7,
LSPP5. For example, a strain lacking all 4 regions was denoted “t1111,” whereas
a strain with genomic material at LSP2 and LSP7, but not at the other two LSPs,
was denoted “t1221.”
High-resolution strain typing by rep-PCR. The DiversiLab System (Bacterial
Barcodes, Athens, GA) was used for high-resolution strain typing, following the
manufacturer’s protocols. rep-PCR takes advantage of repetitive elements inter-
spersed throughout bacterial genomes. When amplified by PCR, these elements
generate highly discriminative genomic fingerprints. The DiversiLab Mycobacte-
rium kit has been shown to deliver resolving power equivalent to that of restric-
tion fragment length polymorphism targeting IS1245 in MAC (5). rep-PCR
required 2 l of 25 to 50 ng/l genomic DNA. Dilutions were performed with
sterile water.
RESULTS
Selection of LSPs. The four LSPs used in this study were
chosen on the basis of their variable occurrence among human
clinical isolates of M. avium. LSP2 and LSP7 were identified by
in silico comparison of the genomes of M. avium strain 104 and
M. avium subsp. paratuberculosis strain K10, followed by mi-
croarray and PCR analysis of genomic DNA of multiple iso-
lates of both subspecies (23). LSP2 encompasses 22,038 bp and
17 ORFs, and LSP7 encompasses 31,474 bp and 25 ORFs.
Both of these regions are present in the 5.48-Mb genome of M.
avium strain 104 and absent in the 4.83-Mb genome of M.
avium subsp. paratuberculosis strain K10.
To avoid bias toward regions that are present in strain 104,
two additional regions were identified that are absent in strain
104 relative to other strains. One such region, HSD, was char-
acterized in a previous genetic analysis of a Seattle clinical
isolate, HMC02 (14). It is 2,631 bp long and codes for a
cytochrome P450-like gene and two type I restriction-modifi-
cation genes, hsdR and hsdM, which are disrupted by insertion
sequences in some clones. In strain 104, there is a deletion of
this region that starts within the P450-like gene and extends
beyond hsdR and hsdM to a right terminus that has not yet
been mapped. Preliminary analysis showed the mapped termi-
nus within the P450-like gene to be well conserved with almost
no polymorphism between strains that carry the deletion.
The fourth LSP, LSPP5, was identified for this study by in
silico analysis. It is a 14,471-bp region that was found by
CROSS_MATCH analysis to be present in M. avium subsp.
paratuberculosis strain K10 but absent in strain 104. It carries
15 ORFs, including multiple transposase genes, indicative of
insertion elements. As preliminary PCR analysis revealed the
bordering regions to be variable between M. avium strains,
PCR primers were designed to hybridize to the conserved
internal and external regions within and outside the variable
border regions.
The 2 LSPs present in strain 104, LSP2 and LSP7, mapped
at positions 5,240,295 to 5,263,079 and 3,210,765 to 3,242,533,
respectively, in the most recent draft of the M. avium 104
genome sequence (www.tigr.org). The genomic region that
amplified between the flanking primers in LSPP5 corre-
sponded to positions 2,622,423 to 2,623,150 in the 104 genome.
The HSD deletion junction mapped to base pair 1,537,166.
Frequency of precise LSP types. Strain 104 plus 207 addi-
tional human clinical isolates of M. avium were evaluated by
PCR for the 4 LSPs. Each isolate was assigned an “LSP type”
that consisted of 4 binary scores for the presence (coded as “2”)
or absence (coded as “1”) of the 4 loci. The scores were listed in
the order HSD, LSP2, LSP7, and LSPP5. Of the 16 possible LSP
types, 14 were found in the sample. Of the 208 isolates, 174 (84%)
yielded amplicons at all four sites of the precise sizes expected
for “present” or “absent” results (Fig. 1). The other 34 strains
yielded indeterminate results at one or more loci. Most inde-
terminate results consisted of failure to amplify at one or more
loci or the occurrence of multiple bands at one or more loci.
Indeterminate results occurred relatively frequently at LSP2
(7.2%) and LSPP5 (6.3%) and less frequently at LSP7 (4.8%)
and HSD (3.8%). The largest geographical sample sets had the
greatest variety of LSP types. The Southern California and The
Netherlands samples exhibited 10 and 8, respectively, of the 16
possible LSP types.
Only one LSP type, t2112, was found in all geographical sites
examined (Fig. 1). This was also the most common LSP type
overall, accounting for 44 (21%) of the 208 strains examined.
The incidence of the t2112 LSP type, and its occurrence in all
geographical regions examined, may reflect an ancestral con-
figuration at most or all of the 4 genomic positions.
Identification of t1221 isolates. Strain 104 exhibited the
t1221 LSP type. In total, 19 t1221 isolates were identified, 12
(63%) of which came from Southern California, a region
that provided 75 (36%) of the 208 isolates examined. Of the
remaining 7 t1221 isolates, 5 came from Seattle, and 1
(each) came from The Netherlands and Brazil (Fig. 1). The
United States t1221 isolates originated from 4 of the 6
Southern California sites and 1 of the 2 Seattle sites. In
addition to the 19 t1221 strains, a single indeterminate
strain from Southern California, W214 (t1X21), had an LSP
type identical to strain 104 at 3 of the 4 loci but failed to
produce an amplicon for LSP2.
High-resolution linkages within LSP types. To identify
t1221 isolates that were genotypically identical to strain 104,
the 18 additional t1221 strains plus the t1X21 indeterminate
strain W214 were typed by rep-PCR, a high-resolution method
(5). Nine t1221 isolates exhibited92% similarity to strain 104
(Fig. 2), a level of similarity that was previously established as
the threshold for strain identity within MAC (5). Strain W214
also fell into this cluster. The remaining eight t1221 isolates,
FIG. 1. Distribution of LSP types. The number of isolates with each
LSP type is shown. Blanks indicate that no isolates were found with a
given LSP type at a given site. The t1221 LSP types are highlighted by
the box.
VOL. 44, 2006 LSP TYPING OF MYCOBACTERIUM AVIUM 785
including isolates from Brazil and The Netherlands, showed
92% similarity on rep-PCR.
The 10 104-like isolates identified in this fashion and strain
104 came from four different hospitals in Southern California
and a fifth hospital in Seattle. Isolation dates spanned a 17-year
period, from 1983 through 1999.
To assess the occurrence of the 104-like rep-PCR type in
strains that did not share the t1221 LSP type, rep-PCR patterns
of 65 non-t1221 strains, representing 11 of the other 13 LSP
types that occurred within the sample, were compared to that
of strain 104. These strains had been typed in separate studies
(40 strains) or were chosen at random (25 strains) for this
comparison. None of these strains exhibited 92% similarity
to strain 104 (Fig. 3).
DISCUSSION
LSP typing proved useful as an inexpensive and expedi-
tious way to screen a large number of clinical isolates of M.
avium for a specific genotype prior to high-resolution typing
by the more expensive rep-PCR method. We have reported
the successful use of a similar model in tuberculosis out-
break monitoring (7). In the present study, we used this
strategy to interrogate a sample of 207 M. avium clinical
FIG. 2. rep-PCR analysis of t1221 isolates and other clinical isolates. The dendrogram and gel-like images were generated by the DiversiLab
software, which also assigned numbers (1 though 24) to the samples in the set. The strain identifications, LSP types, and dates and locations of
collection were added by us, as was the vertical dotted line that marks the 92% similarity cutoff. The Southern California sample collection dates
spanned a decade, with the 100 and 500 series collected in the mid-1980s. The 104-like cluster included isolates numbered 5 through 15.
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isolates for genotypic similarity with the genome sequence
strain 104. Once the 19 isolates with the shared t1221 or
t1X21 type were identified, we focused high-resolution typ-
ing on those isolates. In this manner, we quickly identified
10 additional 104-like isolates from within a large and di-
verse sample set. Not surprisingly, two of these isolates (101
and 103) came from separate patients at the same hospital,
and during the same time period, as strain 104. Less ex-
pected was the isolation of such strains from patients in four
other hospitals in Southern California and Seattle. The re-
sults show that strain 104 has been isolated from multiple
patients over a 17-year period.
The 17-year time span was an unexpected finding. We are
not aware of prior reports of this nature, and there are several
possible models to explain it. A single environmental source of
infection may exist, and the 11 patients may have acquired
their infections from that single source at different time points
over 17 years. Alternatively, the 104-like strain may have stably
colonized multiple environmental sites in the region, resulting
in infection of epidemiologically unlinked patients. A third
scenario is that all 11 patients were exposed to a single point
source in the early 1980s and became stably but asymptomat-
ically colonized. Subsequently, over the course of the ensuing
17 years, they may have become immunocompromised and
FIG. 3. rep-PCR analysis of non-t1221 isolates compared to strain 104. The dendrogram and gel-like images were generated by the DiversiLab
software. The strain identifications, LSP types, and 92% similarity cutoff line were added by us, as for Fig. 2. Strain 104 is isolate number 14 on
the figure.
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developed MAC disease at differing times and locales. These
divergent models highlight an unanswered question in MAC
disease. Namely, is the pathogen acquired early in life and
asymptomatically carried until host immunity fails, or is MAC
acquisition transient and cleared unless a preexisting suscepti-
bility exists? To answer these questions and to better define
models of MAC acquisition, large numbers of clinical and
environmental isolates will have to be analyzed from multiple
sites. The PCR-based LSP typing would greatly facilitate such
a study.
LSP typing successfully narrowed the search for the 104-like
genotype, as indicated by the fact that 104-like isolates were
common among t1221 and t1X21 strains but were not found in
a sample of 65 strains with other LSP types. However, it was
also noted that the non-t1221 sample included strains that
appeared similar or identical to each other by rep-PCR but had
differing LSP types (Fig. 3). This observation indicates that
LSP types can, in some instances, segregate rapidly and inde-
pendently of other genotypic parameters.
In contrast to a previous LSP-based study conducted on M.
tuberculosis (7), which targeted LSPs that were unique to a
single Beijing family outbreak strain, the LSPs used in this
study of M. avium strains were broadly heterogeneous among
isolates from 3 continents, as evidenced by the variety in LSP
types observed. Therefore, the specific LSP tests used in this
study can be applied to any molecular epidemiologic analysis
of clinical M. avium.
In theory, both the resolving power and the throughput of
LSP typing can be further improved. Analysis of additional
LSPs will improve the resolution of the test, and probes for
these LSPs can be incorporated into filter-based, high-through-
put formats similar to that described for “deligotyping” of M.
tuberculosis (9). Alternatively, these four LSP loci could be
combined with the recently described M. avium variable num-
ber of tandem repeats-mycobacterial interspersed repetitive
unit loci (21) for a multimodal PCR-based genotyping method.
An advantage of LSP typing is that its binary readout is por-
table, meaning that results can be expressed in spreadsheet
form and compared between laboratories. As illustrated by the
identification of 104-like clones, LSP typing can be used as a
high-throughput, moderate-resolution tool to expedite
searches for shared genotypic identity.
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